Puerarin: A review of pharmacological effects

Phytotherapy Research

Volumn 28, Issue 7, 2014, Pages 961-975

  Zhou, Yan Xi ^a,b   Zhang, Hong ^b   Peng, Cheng ^a  

^a CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

pharmacology; Pueraria lobata; puerarin

Indexed keywords

ADENYLATE KINASE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PUERARIN; PURINERGIC P2X3 RECEPTOR; THROMBOSPONDIN 1;

ACUTE HEART INFARCTION; ALTERNATIVE MEDICINE; ANALGESIC ACTIVITY; ANTI PARKINSON DISEASE ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOSTEOPOROTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPYRETIC ACTIVITY; APOPTOSIS; BRAIN ISCHEMIA; CHINESE MEDICINE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG STRUCTURE; DRUG TARGETING; EAR EDEMA; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; LIVER INJURY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PHYTOCHEMISTRY; PHYTOESTROGENIC ACTIVITY; PUERARIA LOBATA; REPERFUSION INJURY; REVIEW; VASODILATORY ACTIVITY; VIRUS MYOCARDITIS;

PUERARIA MONTANA VAR. LOBATA;

PHARMACOLOGY; PUERARIA LOBATA; PUERARIN;

ANIMALS; DRUGS, CHINESE HERBAL; HUMANS; ISOFLAVONES; PLANT ROOTS; PUERARIA;

EID: 84904262184     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5083     Document Type: Review

References (174)

1. Bai QH, Li WM, Liu HT, et al,. 2010. Puerarin antagonizes activation effect of LPS on N9 microglia cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 26: 227-230.
2. +-induced neurotoxicity in PC12 cells mediated by inhibiting mitochondrial dysfunction and caspase-3-like activation. Neurosci Res 53: 183-188. (Pubitemid 41219535)
3. Brenner R, Perez GJ, Bonev AD, et al,. 2000. Vasoregulation by the β1 subunit of the calcium-activated potassium channel. Nature 407: 870-876.
4. Cai H, Wu LL, Sun XC, et al,. 2011. Effects of puerarin on proliferation and differentiation of umbilical cord mesenchymal stem cells into osteoblasts in vitro. Yao Xue Xue Bao 46: 738-741.
5. Chang Y, Hsieh CY, Peng ZA, et al,. 2009. Neuroprotective mechanisms of puerarin in middle cerebral artery occlusion-induced brain infarction in rats. J Biomed Sci 16: 19.
6. Chen C, Chen C, Wang Z, et al,. 2012a. Puerarin induces mitochondria-dependent apoptosis in hypoxic human pulmonary arterial smooth muscle cells. PLoS One 7: e34181.
7. Chen C, Wang ZY, Wang LX, et al,. 2011a. Effects of puerarin on proliferation, apoptosis and Kv1.5 gene expression of pulmonary artery smooth muscle cells induced by hypoxia. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 29: 731-734.
8. Chen CC, Chan WH,. 2009. Impact effects of puerarin on mouse embryonic development. Reprod Toxicol 28: 530-535.
9. Chen F, Zhang HQ, Zhu J, et al,. 2012b. Puerarin enhances superoxide dismutase activity and inhibits RAGE and VEGF expression in retinas of STZ-induced early diabetic rats. Asian Pac J Trop Med 5: 891-896.
10. Chen JW, Tao S, Luo R, et al,. 2008. Molecular mechanism of reversing multi-drug resistance of K562/AO2 by puerarin. Zhong Nan Da Xue Xue Bao Yi Xue Ban 33: 216-221.
11. Chen R, Xue J, Xie M,. 2012c. Puerarin prevents isoprenaline-induced myocardial fibrosis in mice by reduction of myocardial TGF-β1 expression. J Nutr Biochem 23: 1080-1085.
12. Chen Y, Chen C, Shi S, et al,. 2011b. Endometriotic implants regress in rat models treated with puerarin by decreasing estradiol level. Reprod Sci 18: 886-891.
13. Chen YY, Chen J, Zhou XM, et al,. 2012d. Puerarin protects human umbilical vein endothelial cells against high glucose-induced apoptosis by upregulating heme oxygenase-1 and inhibiting calpain activation. Fundam Clin Pharmacol 26: 322-331.
14. Cheng W, Chen L, Yang S, et al,. 2012. Puerarin suppresses proliferation of endometriotic stromal cells partly via the MAPK signaling pathway induced by 17β-estradiol-BSA. PLoS One 7: e45529.
15. Cheng Y, Zhu G, Guan Y, et al,. 2011. Protective effects of puerarin against 1-methyl-4-phenylpyridinium-induced mitochondrial apoptotic death in differentiated SH-SY5Y cells. Zhongguo Zhong Yao Za Zhi 36: 1222-1226.
16. Cheng YF, Zhu GQ, Wang M, et al,. 2009. Involvement of ubiquitin proteasome system in protective mechanisms of Puerarin to MPP(+)-elicited apoptosis. Neurosci Res 63: 52-58.
17. Choi YM, Jun HJ, Dawson K, et al,. 2010. Effects of the isoflavone puerarin and its glycosides on melanogenesis in B16 melanocytes. Eur Food Res Technol 231: 75-83.
18. Chung MJ, Sung NJ, Park CS, et al,. 2008. Antioxidative and hypocholesterolemic activities of water-soluble puerarin glycosides in HepG2 cells and in C57 BL/6 J mice. Eur J Pharmacol 578: 159-170. (Pubitemid 350309595)
19. Cui SQ,. 2011. Effect of puerarin in myocardial protection in rats with acute and chronic alcoholism. Nan Fang Yi Ke Da Xue Xue Bao 31: 2035-2038.
20. Deng Y, Ng ES, Yeung JH, et al,. 2012. Mechanisms of the cerebral vasodilator actions of isoflavonoids of Gegen on rat isolated basilar artery. J Ethnopharmacol 139: 294-304.
21. Ding MP, Feng F, Hu HT,. 2007. Effects of puerarin on expression of nuclear factor kappaB after cerebral ischemia/reperfusion in rats. Zhongguo Zhong Yao Za Zhi 32: 2515-2518.
22. Gao L, Ji X, Song J, et al,. 2009a. Puerarin protects against ischemic brain injury in a rat model of transient focal ischemia. Neurol Res 31: 402-406.
23. Gao L, Li W, Kuang HY,. 2009b. Of berberine and puerarin on dexamethesone-induced insulin resistance in porcine ovarian thecal cells. Zhongguo Zhong Xi Yi Jie He Za Zhi 29: 623-627.
24. Gao Q, Pan HY, Qiu S, et al,. 2006. Atractyloside and 5-hydroxydecanoate block the protective effect of puerarin in isolated rat. Life Sci 79: 217-224. (Pubitemid 43782549)
25. Gao Q, Yang B, Ye ZG, et al,. 2007. Opening the calcium-activated potassium channel participates in the cardioprotective effect of puerarin. Eur J Pharmacol 574: 179-184. (Pubitemid 47575526)
26. Gu L, Yang Y, Sun Y, Zheng X,. 2010. Puerarin inhibits acid-sensing ion channels and protects against neuron death induced by acidosis. Planta Med 76: 583-588.
27. Guo C, Xu L, He Q, et al,. 2013. Anti-fibrotic effects of puerarin on CCl4-induced hepatic fibrosis in rats possibly through the regulation of PPAR-γ expression and inhibition of PI3K/Akt pathway. Food Chem Toxicol 56C: 436-442.
28. Guo XG, Chen JZ, Zhang X, Xia Q,. 2004. Effect of puerarin on l -type calcium channel in isolated rat ventricular myocytes. Zhongguo Zhong Yao Za Zhi 29: 248-251.
29. Han J, Yu CQ, Shen W,. 2009. Inhibitory effects of puerarin on invasion and metastasis of oophoroma cells HO-8910. Zhongguo Zhong Xi Yi Jie He Za Zhi 29: 632-635.
30. Han JQ, Yu KY, He M,. 2012. Effects of puerarin on the neurocyte apoptosis and p-Akt (Ser473) expressions in rats with cerebral ischemia/reperfusion injury. Zhongguo Zhong Xi Yi Jie He Za Zhi 32: 1069-1072.
31. Hao LN, He SZ, Luo XM, et al,. 2008. The effect of puerarin on prevention of oxidative damage of cultured lens capsule epithelial cells. Zhonghua Yan Ke Za Zhi 44: 163-169.
32. Hao LN, He SZ, Shen YH, et al,. 2011a. Protective effects of puerarin on lens epithelial cells in rat diabetic cataract. Zhonghua Yan Ke Za Zhi 47: 320-326.
33. Hao LN, Wang M, Ma JL, Yang T,. 2012. Puerarin decreases apoptosis of retinal pigment epithelial cells in diabetic rats by reducing peroxynitrite level and iNOS expression. Sheng Li Xue Bao 64: 199-206.
34. Hao LN, Zhang YQ, Shen YH, et al,. 2010. Effect of puerarin on retinal pigment epithelial cells in diabetic rats by reducing peroxynitrite level and iNOS expression. Int J Ophthalmol 3: 283-287.
35. Hao LN, Zhang YQ, Shen YH, et al,. 2011b. Inducible nitric oxide synthase and Fas/FasL with C3 expression of mouse retinal pigment epithelial cells in response to stimulation by peroxynitrite and antagonism of puerarin. Chin Med J (Engl) 124: 2522-2529.
36. Heng LS, Lan BS, Jia Z, et al,. 2009. Protective effect of puerarin on the secondary spinal cord injury in rats. Zhong Yao Cai 32: 395-397.
37. Hien TT, Kim HG, Han EH, et al,. 2010. Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-κB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells. Mol Nutr Food Res 54: 918-928.
38. Hou SZ, Su ZR, Chen SX, et al,. 2011. Role of the interaction between puerarin and the erythrocyte membrane in puerarin-induced hemolysis. Chem Biol Interact 192: 184-192.
39. Hsiang SW, Lee HC, Tsai FJ, et al,. 2011. Puerarin accelerates peripheral nerve regeneration. Am J Chin Med 39: 1207-1217.
40. Hsu FL, Liu IM, Kuo DH, et al,. 2003. Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats. J Nat Prod 66: 788-792.
41. Hsu YA, Sheu JJ, Lai CH, et al,. 2009. Puerariae radix isoflavones and their metabolites inhibit growth and induce apoptosis in breast cancer cells. Biochem Biophys Res Commun 378: 683-688.
42. Hu JJ, Zhang DD, Chen JJ, et al,. 2012. Effect of pretreatment with puerarin on activation of LPS-induced RAW264. 7 cells. Zhongguo Zhong Yao Za Zhi 37: 3112-3116.
43. Hu W, Yang X, Zhe C, et al,. 2011. Puerarin inhibits iNOS, COX-2 and CRP expression via suppression of NF-κB activation in LPS-induced RAW264.7 macrophage cells. Pharmacol Rep 63: 781-789.
44. Hu W, Zhang Q, Yang X, et al,. 2010. Puerarin inhibits adhesion molecule expression in tnf-alpha-stimulated human endothelial cells via modulation of the nuclear factor kappaB pathway. Pharmacology 85: 27-35.
45. Huang F, Liu K, Du H, et al,. 2012a. Puerarin attenuates endothelial insulin resistance through inhibition of inflammatory response in an IKKβ/IRS-1-dependent manner. Biochimie 94: 1143-50.
46. Huang MQ, Yang ZX, Yao MZ, et al,. 2012b. Puerarin inhibits DNA damage of HaCaT cells induced by UVB via ceramide pathway. Yao Xue Xue Bao 47: 609-613.
47. Huang ZH, He GX, Zhang ZJ, et al,. 1992. Effect d Puerarin on bovine arterial endothelial cells. J Gerontol 12: 350-351.
48. Hwang YP, Choi CY, Chung YC, et al,. 2007. Protective effects of puerarin on carbon tetrachloride-induced hepatotoxicity. Arch Pharm Res 30: 1309-1317.
49. Hwang YP, Jeong HG,. 2008. Mechanism of phytoestrogen puerarin-mediated cytoprotection following oxidative injury: estrogen receptor-dependent up-regulation of PI3K/Akt and HO-1. Toxicol Appl Pharmacol 233: 371-381.
50. Hwang YP, Kim HG, Hien TT, et al,. 2011. Puerarin activates endothelial nitric oxide synthase through estrogen receptor-dependent PI3-kinase and calcium-dependent AMP-activated protein kinase. Toxicol Appl Pharmacol 257: 48-58.
51. Jin G, Yang P, Gong Y, et al,. 2009. Effects of puerarin on expression of apelin and its receptor of 2K1C renal hypertension rats. Zhongguo Zhong Yao Za Zhi 34: 3263-3267.
52. Kato E, Kawabata J,. 2010. Glucose uptake enhancing activity of puerarin and the role of C-glucoside suggested from activity of related compounds. Bioorg Med Chem Lett 20: 4333-4336.
53. Kim J, Kim KM, Kim CS, et al,. 2012. Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stress. Free Radic Biol Med 53: 357-365.
54. Kim KM, Jung DH, Jang DS, et al,. 2010. Puerarin suppresses AGEs-induced inflammation in mouse mesangial cells: a possible pathway through the induction of heme oxygenase-1 expression. Toxicol Appl Pharmacol 244: 106-113.
55. Lee OH, Seo DH, Park CS, Kim YC,. 2010. Puerarin enhances adipocyte differentiation, adiponectin expression, and antioxidant response in 3T3-L1 cells. Biofactors 36: 459-467.
56. Lee SJ, Baek HJ, Lee CH, Kim HP,. 1994. Antiinflammatory activity of isoflavonoids from Pueraria radix and biochanin A derivatives. Arch Pharm Res pp. 31-35. (Pubitemid 24125176)
57. Li J, Wang G, Liu J, et al,. 2010. Puerarin attenuates amyloid-beta-induced cognitive impairment through suppression of apoptosis in rat hippocampus in vivo. Eur J Pharmacol 649: 195-201.
58. Li Q, Xiao Y, Gong H, et al,. 2009. Effect of puerarin on the expression of extracellular matrix in rats with streptozotocin-induced diabetic nephropathy. Natl Med J India 22: 9-12.
59. Li Q, Zhang X, Zhu F, Zhang Z,. 2007. Study of regulation of Puerarin on blood P-selectin and the expression of aorta VCAM mRNA in diabetes. Wei Sheng Yan Jiu 36: 581-3, 595.
60. Li QX, Zhong HJ, Gong HR, et al,. 2008a. Effect of compound Puerarin on the collage IV in streptozotocin-induced diabetic nephropathy rats. Zhonghua Yu Fang Yi Xue Za Zhi 42: 254-259.
61. Li R, Xu L, Liang T, et al,. 2013. Puerarin mediates hepatoprotection against CCl4-induced hepatic fibrosis rats through attenuation of inflammation response and amelioration of metabolic function. Food Chem Toxicol 52: 69-75.
62. Li X, Sun S, Tong E,. 2003. Experimental study on the protective effect of puerarin to Parkinson disease. J Huazhong Univ Sci Technolog Med Sci 23: 148-150. (Pubitemid 41559742)
63. Li X, Zhang J, Gao Y, et al,. 2011. Puerarin alleviates burn-related procedural pain mediated by P2X3 receptors. Purinergic Signal 7: 489-497.
64. Li YW, Cai ZL, Shen W, et al,. 2008b. Regulation of aromatase P450 expression by puerarin in endometrial cell line RL95-2. Zhong Xi Yi Jie He Xue Bao 6: 1017-1023.
65. Liang J, Chen H, Pan W, Xu C,. 2012. Puerarin inhibits caspase-3 expression in osteoblasts of diabetic rats. Mol Med Rep 5: 1419-1422.
66. Liang S, Xu C, Li G, Gao Y,. 2010. P2X receptors and modulation of pain transmission: focus on effects of drugs and compounds used in traditional Chinese medicine. Neurochem Int 57: 705-712.
67. Lin F, Xie B, Cai F, Wu G,. 2012. Protective effect of Puerarin on β-amyloid-induced neurotoxicity in rat hippocampal neurons. Arzneimittelforschung 62: 187-193.
68. Lin YJ, Hou YC, Lin CH, et al,. 2009. Puerariae radix isoflavones and their metabolites inhibit growth and induce apoptosis in breast cancer cells. Biochem Biophys Res Commun 378: 683-688.
69. Liu CM, Ma JQ, Sun YZ,. 2011. Protective role of puerarin on lead-induced alterations of the hepatic glutathione antioxidant system and hyperlipidemia in rats. Food Chem Toxicol 49: 3119-3127.
70. Liu CM, Ma JQ, Sun YZ,. 2012a. Puerarin protects rat kidney from lead-induced apoptosis by modulating the PI3K/Akt/eNOS pathway. Toxicol Appl Pharmacol 258: 330-342.
71. Liu CM, Ma JQ, Sun YZ,. 2012b. Puerarin protects the rat liver against oxidative stress-mediated DNA damage and apoptosis induced by lead. Exp Toxicol Pathol 64: 575-582.
72. Liu CM, Zheng GH, Ming QL, et al,. 2013. Protective effect of puerarin on lead-induced mouse cognitive impairment via altering activities of acetyl cholinesterase, monoamine oxidase and nitric oxide synthase. Environ Toxicol Pharmacol 35: 502-510.
73. Liu Q, Lu Z, Wang L,. 2000. Restrictive effect of puerarin on myocardial infarct area in dogs and its possible mechanism. J Tongji Med Univ 20: 43-45. (Pubitemid 33210417)
74. 2+. Zhongguo Zhong Yao Za Zhi 32: 2058-2062.
75. Liu XJ, Zhao J, Gu XY,. 2010. The effects of genistein and puerarin on the activation of nuclear actor-kappaB and the production of tumor necrosis factor-alpha in asthma patients. Pharmazie 65: 127-131.
76. Lu N, Zhang Y, Gao Z,. 2009. Nitrite-glucose-glucose oxidase system directly induces rat heart homogenate oxidation and tyrosine nitration: effects of some flavonoids. Toxicol In Vitro 23: 627-633.
77. Lu XR, Zhu QL,. 1998. Effects of Puerarin on experimental hyperlipidemia in rabbits. Naunyn Schnfiedebergss Arch Phannacol 358 (suppl 2): R486.
78. Malaivijitnond S, Tungmunnithum D, Gittarasanee S, et al,. 2010. Puerarin exhibits weak estrogenic activity in female rats. Fitoterapia 81: 569-576.
79. Mao CP, Gu ZL,. 2005. Puerarin reduces increased c-fos, c-jun, and type IV collagen expression caused by high glucose in glomerular mesangial cells. Acta Pharmacol Sin 26: 982-986.
80. Meng P, Zhou D, Hu X,. 1999. Clinical observation on the treatment of infantile viral myocarditis with puerarin. Zhongguo Zhong Xi Yi Jie He Za Zhi 19: 647-648.
81. Meng XH, Ni C, Zhu L, et al,. 2009. Puerarin protects against high glucose-induced acute vascular dysfunction: role of heme oxygenase-1 in rat thoracic aorta. Vascul Pharmacol 50: 110-115.
82. Michihara S, Tanaka T, Uzawa Y, et al,. 2012. Puerarin exerted anti-osteoporotic action independent of estrogen receptor-mediated pathway. J Nutr Sci Vitaminol (Tokyo) 58: 202-209.
83. Noh BK, Lee JK, Jun HJ, et al,. 2011. Restoration of autophagy by puerarin in ethanol-treated hepatocytes via the activation of AMP-activated protein kinase. Biochem Biophys Res Commun 414: 361-366.
84. Overstreet DH, Kralic JE, Morrow AL, et al,. 2003. NPI-031G (puerarin) reduces anxiogenic effects of alcohol withdrawal or benzodiazepine inverse or 5-HT2C agonists. Pharmacol Biochem Behav 75: 619-625. (Pubitemid 36939172)
85. Overstreet DH, Ma ZZ, Lee DYW,. 2002. The isoflavone puerarin reduces anxiety symptoms induced by acute 5-HT2C or inverse benzodiazepine agonists or alcohol withdrawal. Eur Neuropsychopharmacol 12: 361-365.
86. Pan HP, Li G,. 2008. Protecting mechanism of puerarin on the brain neurocyte of rat in acute local ischemia brain injury and local cerebral ischemia-reperfusion injury. Yakugaku Zasshi 128: 1689-1698.
87. Pan ZY, Bao ZS, Wu ZM, et al,. 2009. The myocardial protective effects of puerarin on STZ-induced diabetic rats. Fen Zi Xi Bao Sheng Wu Xue Bao 42: 137-144.
88. Pang W, Lan XM, Wang CB,. 2012. Effect of puerarin on the release of interleukin-8 in co-culture of human bronchial epithelial cells and neutrophils. Chin J Integr Med 18: 283-287.
89. Park OJ, Surh YJ,. 2004. Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies. Toxicol Lett 150: 43-56 (Pubitemid 38447236)
90. Penetar DM, Toto LH, Farmer SL, et al,. 2012. The isoflavone puerarin reduces alcohol intake in heavy drinkers: a pilot study. Drug Alcohol Depend 126: 251-256.
91. Peng JH, Cui T, Huang F, et al,. 2013. Puerarin ameliorates experimental alcoholic liver injury by inhibition of endotoxin gut leakage, Kupffer cell activation, and endotoxin receptors expression. J Pharmacol Exp Ther 344: 646-654.
92. Prasain JK, Jones K, Kirk M, et al,. 2003. Profiling and quantification of isoflavonoids in kudzu dietary supplements by high-performance liquid chromatography and electrospray ionization tandem mass spectrometry. J Agric Food Chem 51: 4213-4218.
93. Prasain JK, Peng N, Rajbhandari R, Wyss JM,. 2012. The Chinese Pueraria root extract (Pueraria lobata) ameliorates impaired glucose and lipid metabolism in obese mice. Phytomedicine 20: 17-23.
94. Rachoń D, Vortherms T, Seidlova-Wuttke D, Wuttke W,. 2007. Dietary daidzein and puerarin do not affect pituitary LH expression but exert uterotropic effects in ovariectomized rats. Maturitas 57: 161-170. (Pubitemid 46771028)
95. Rezvani AH, Overstreet DH, Perfumi M, Massi M,. 2003. Plant derivatives in the treatment of alcohol dependency. Pharmacol Biochem Behav 75: 593-606. (Pubitemid 36936894)
96. Rong H, Keukeleire DD, Cooman LD,. 2002. Chapter 5: chemical constituents of Pueraria plants: identification and methods of analysis. In:, Keung, W.M., (Ed.), Pueraria: The Genus Pueraria. CRC Press, USA, 23-25.
97. Sarkar FH, Li Y,. 2003. Soy isoflavones and cancer prevention. Cancer Invest 21: 744-757. (Pubitemid 37377330)
98. Shao HM, Tang YH, Jiang PJ, et al,. 2010. Inhibitory effect of flavonoids of puerarin on proliferation of different human acutemyeloid leukemia cell lines in vitro. Zhongguo Shi Yan Xue Ye Xue Za Zhi 18: 296-299.
99. Shen JG, Yao MF, Chen XC, et al,. 2009. Effects of puerarin on receptor for advanced glycation end products in nephridial tissue of streptozotocin- induced diabetic rats. Mol Biol Rep 36: 2229-2233.
100. Sheu SY, Tsai CC, Sun JS, et al,. 2012. Stimulatory effect of puerarin on bone formation through co-activation of nitric oxide and bone morphogenetic protein-2/mitogen-activated protein kinases pathways in mice. Chin Med J (Engl) 125: 3646-5363.
101. Sun W, Zheng XZ, Xu QL, et al,. 2008. Effects of puerarin on ADRP gene expression in fatty tissue of type 2 diabetes mellitus rats. Zhongguo Zhong Yao Za Zhi 33: 2026-2028, 2060.
102. Sun XH, Ding JP, Li H, et al,. 2007. Activation of large-conductance calcium-activated potassium channels by puerarin: the underlying mechanism of puerarin-mediated vasodilation. J Pharmacol Exp Ther 323: 391-397. (Pubitemid 47443248)
103. Tang X, Zhu X, Liu S, et al,. 2008. Phytoestrogens induce differential estrogen receptor β-mediated responses in transfected MG-63 cells. Endocrine 34: 29-35.
104. Tang XL, Liu XJ, Tian Q, Zhang W,. 2012. Dynamic oxidative stress and DNA damage induced by oestrogen deficiency and protective effects of puerarinand 17β-oestradiol in ovariectomized rats. Basic Clin Pharmacol Toxicol 111: 87-91.
105. Tang YH, Zhu HQ, Zhang YC, et al,. 2010. Apoptosis of NB4 cells induced by flavonoids of puerarin in vitro. Zhongguo Shi Yan Xue Ye Xue Za Zhi 18: 326-329.
106. Teng Y, Cui H, Yang M, et al,. 2009. Protective effect of puerarin on diabetic retinopathy in rat. Mol Biol Rep 36: 1129-1133.
107. Thielemann A, Wuttke W, Wuttke M, Seidlova-Wuttke D,. 2010. Comparison of urodynamic effects of phytoestrogens equol, puerarin and genistein with these of estradiol 17 b in ovariectomized rats. Exp Gerontol 45: 129-137.
108. Tian F, Xu LH, Zhao W, et al,. 2011. The optimal therapeutic timing and mechanism of puerarin treatment of spinal cord ischemia-reperfusion injury in rats. J Ethnopharmacol 134: 892-896.
109. Tiyasatkulkovit W, Charoenphandhu N, Wongdee K, et al,. 2012. Upregulation of osteoblastic differentiation marker mRNA expression in osteoblast-like UMR106 cells by puerarin and phytoestrogens from Pueraria mirifica. Phytomedicine 19: 1147-1155.
110. Wang D, Liu Y, Han J, et al,. 2011a. Puerarin suppresses invasion and vascularization of endometriosis tissue stimulated by 17β-estradiol. PLoS One 6: e25011.
111. Wang G, Zhou L, Zhang Y, et al,. 2011b. Implication of the c-Jun-NH2-terminal kinase pathway in the neuroprotective effect of puerarin against 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in PC-12 cells. Neurosci Lett 487: 88-93.
112. Wang JW, Gao JM, Huang YJ,. 2012a. Effects of puerarin on the vascular active factor related to cerebral vasospasm after aneurysm subarachnoid hemorrhage. Zhongguo Zhong Xi Yi Jie He Za Zhi 32: 164-167.
113. Wang L, Lin S, Li Z, et al,. 2013. Protective effects of puerarin on experimental chronic lead nephrotoxicity in immature female rats. Hum Exp Toxicol 32: 172-185.
114. Wang PP, Zhu XF, Yang L, et al,. 2012b. Puerarin stimulates osteoblasts differentiation and bone formation through estrogen receptor, p38 MAPK, and Wnt/β-catenin pathways. J Asian Nat Prod Res 14: 897-905.
115. Wang Q, Wu T, Chen X, et al,. 2006. Puerarin injection for unstable angina pectoris. Cochrane Database Syst Rev 3, doi: 10.1002/14651858.CD004196. pub2.
116. Wang R, Wang L, Zhang WX,. et al. 2012c. Protective effects of puerarin on 60Co-gamma-induced acute injury of sertoli cells of testis in mice. Zhongguo Zhong Xi Yi Jie He Za Zhi 32: 385-389.
117. Wang Y, Yin L, Li Y, et al,. 2008. Preventive effects of puerarin on alcohol-induced osteonecrosis. Clin Orthop Relat Res 466: 1059-1067.
118. Wong KH, Li GQ, Li KM, et al,. 2011. Kudzu root: traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases. J Ethnopharmacol 134: 584-607.
119. Wong R, Rabie B,. 2003. Effect of puerarin on bone formation. Beijing Da Xue Xue Bao 35: 74-77.
120. Wu GL, Chen J, Yu GY, et al,. 2008. Effect of puerarin on levels of TGF-beta1 and alpha-SMA in rats with alcoholic injury liver. Zhongguo Zhong Yao Za Zhi 33: 2245-2249.
121. Wu HQ, Guo HN, Wang HQ, et al,. 2009. Protective effects and mechanism of puerarin on learning-memory disorder after global cerebral ischemia-reperfusion injury in rats. Chin J Integr Med 15: 54-59.
122. Xie W, Du L,. 2011. Diabetes is an inflammatory disease: evidence from traditional Chinese medicines. Diabetes Obes Metab 13: 289-301.
123. Xing G, Dong M, Li X, et al,. 2011. Neuroprotective effects of puerarin against beta-amyloid-induced neurotoxicity in PC12 cells via a PI3K-dependent signaling pathway. Brain Res Bull 85: 212-218.
124. Xiong FL, Sun XH, Gan L, et al,. 2006. Puerarin protects rat pancreatic islets from damage by hydrogen peroxide. Eur J Pharmacol 529: 1-7.
125. Xu C, Li G, Gao Y, et al,. 2009. Effect of puerarin on P2X3 receptor involved in hyperalgesia after burn injury in the rat. Brain Res Bull 80: 341-346.
126. Xu C, Xu W, Xu H, et al,. 2012. Role of puerarin in the signalling of neuropathic pain mediated by P2X3 receptor of dorsal root ganglion neurons. Brain Res Bull 87: 37-43.
127. Xu HX, Fu Y, Li HJ,. 2011. Mechanism of advanced glycation end-products in the inducement of apoptosis of human gingival fibroblast and related effect of puerarin in the process. Zhonghua Kou Qiang Yi Xue Za Zhi 46: 31-34.
128. Xu X, Zheng X,. 2007. Potential involvement of calcium and nitric oxide in protective effects of puerarin on oxygen-glucose deprivation in cultured hippocampal neurons. J Ethnopharmacol 113: 421-426. (Pubitemid 47361557)
129. Xu XH, Zhang ZG,. 2002. Effect of puerarin on learning-memory behavior and synaptic structure of hippocampus in the aging mice induced by d -galactose. Acta Pharmaceutica Sinica (Chin) 37: 1-4.
130. Xu XH, Zheng XX, Zhou Q, Li H,. 2007. Inhibition of excitatory amino acid efflux contributes to protective effects of puerarin against cerebral ischemia in rats. Biomed Environ Sci 20: 336-342. (Pubitemid 47441814)
131. Yan LP, Zhuang YL, Chan SW, et al,. 2009. Analysis of the mechanisms underlying the endothelium-dependent antivasoconstriction of puerarin in rat aorta. Naunyn Schmiedebergs Arch Pharmacol 379: 587-597.
132. Yang B, Gao Q, Yao H, Xia Q,. 2008. Mitochondrial mechanism of cardioprotective effect of puerarin against H2O2-stress in rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi 24: 399-404.
133. Yang F, Zhang R, He F, et al,. 2012. Osteoblast response to puerarin-loaded porous titanium surfaces: an in vitro study. J Biomed Mater Res A 100: 1419-1426.
134. Yang GJ, Zhang IS, Fan LL,. 1990. Effects of Puerarin against angina pectoris and on TXA2 and PGI2 in patients with coronary heart disease. J Integr Tradit and West Med 10: 82-84.
135. Yang S, Lou JL, Wang Q,. 2009. Effect of puerarin on liver injury in KKAy mice with type 2 diabetes mellitus. Zhongguo Zhong Xi Yi Jie He Za Zhi 29: 707-710.
136. Yang X, Hu W, Zhang Q, et al,. 2010. Puerarin inhibits C-reactive protein expression via suppression of nuclear factor kappaB activation in lipopolysaccharide-induced peripheral blood mononuclear cells of patients with stable angina pectoris. Basic Clin Pharmacol Toxicol 107: 637-642.
137. Yao XJ, Yin JA, Xia YF, et al,. 2012. Puerarin exerts antipyretic effect on LPS-induced fever in rats involving inhibition of pyrogen production from macrophages. J Ethnopharmacol 141: 322-330.
138. Yeung DK, Leung SW, Xu YC, et al,. 2006. Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery. Eur J Pharmacol 552: 105-111. (Pubitemid 44649298)
139. Yu C, Li Y, Chen H, et al,. 2008. Decreased expression of aromatase in the Ishikawa and RL95-2 cells by the isoflavone, puerarin, is associated with inhibition of c-jun expression and AP-1 activity. Food Chem Toxicol 46: 3671-3676.
140. Yu CQ, Yu J, Han J, et al,. 2009. Regulatory mechanism of malignant behavior of endometriosis mediated by puerarin. Zhong Xi Yi Jie He Xue Bao 7: 41-47.
141. Yu Z, Li W,. 2006. Induction of apoptosis by puerarin in colon cancer HT-29 cells. Cancer Lett 238: 53-60. (Pubitemid 43851146)
142. Yue PF, Hai-Long Yuan HL, Zhu WF, et al,. 2008. The study to reduce the hemolysis side effect of puerarin by a submicron emulsion delivery system. Biol Pharm Bull 31: 45-50.
143. + current in rat ventricular myocytes. Acta Pharmaco-logica Sinica 24: 1212-1216.
144. Zhang H, Liu Y, Lao M, et al,. 2011a. Puerarin protects Alzheimer's disease neuronal cybrids from oxidant-stress induced apoptosis by inhibiting pro-death signaling pathways. Exp Gerontol 46: 30-37.
145. Zhang H, Zhang L, Zhang Q, et al,. 2011b. Puerarin a novel antagonist to inward rectifier potassium channel (IK1). Mol Cell Biochem 352: 117-123.
146. Zhang HY, Hu HT, Liu YH, et al,. 2008a. Effect of puerarin on PC12 cells apoptosis induced by Abeta25-35 in vitro. Zhong Yao Cai 31: 543-546.
147. Zhang HY, Liu YH, Wang HQ, et al,. 2008b. Puerarin protects PC12 cells against beta-amyloid-induced cell injury. Cell Biol Int 32: 1230-1237.
148. Zhang J, Li X, Gao Y, et al,. 2012a. Effects of puerarin on the inflammatory role of burn-related procedural pain mediated by P2X(7) receptors. Burns pii:S0305-4179(12)00262-8.
149. Zhang MY, Qiang H, Yang HQ, et al,. 2012b. In vitro and in vivo effects of puerarin on promotion of osteoblast bone formation. Chin J Integr Med 18: 276-282.
150. Zhang MY, Shi ZB, Yang HQ, et al,. 2008c. Effects of different doses of puerarin on vascular endothelial cell proliferation in vitro. Zhong Xi Yi Jie He Xue Bao 6: 942-945.
151. Zhang NB, Huang ZG, Cui WD, Ding BP,. 2011c. Effects of puerarin on expression of cardiac Smad3 and Smad7 mRNA in spontaneously hypertensive rat. J Ethnopharmacol 138: 737-740.
152. 2-induced apoptosis through the PI3K/Akt signalling pathway. Cell Biol Int 36: 419-426.
153. Zhang R, Guo HN, Wu HQ, et al,. 2011d. Effect of puerarin on the expression of NMDA receptor in the hippocampus CA1 region after focal cerebral ischemia in rats. Sichuan Da Xue Xue Bao Yi Xue Ban 42: 52-55.
154. Zhang S, Ji G, Liu J,. 2006. Reversal of chemical-induced liver fibrosis in Wistar rats by puerarin. J Nutr Biochem 17: 485-491. (Pubitemid 43867250)
155. Zhang SY, Chen G, Wei PF, et al,. 2008d. The effect of puerarin on serum nitric oxide concentration and myocardial eNOS expression in rats with myocardial infarction. J Asian Nat Prod Res 10: 373-381.
156. Zhang W, Liu CQ, Wang PW, et al,. 2010a. Puerarin improves insulin resistance and modulates adipokine expression in rats fed a high-fat diet. Eur J Pharmacol 649: 398-402.
157. Zhang X, Zhao F, Zhang X, Sheng J,. 2011e. Puerarin induced apoptosis of pulmonary artery smooth muscle cell by mitochondrial pathway. Zhongguo Zhong Yao Za Zhi 36: 2255-2258.
158. Zhang Y, Zeng X, Zhang L, Zheng X,. 2007. Stimulatory effect of puerarin on bone formation through activation of PI3K/Akt pathway in rat calvaria osteoblasts. Planta Med 73: 341-347. (Pubitemid 46910416)
159. Zhang Z, Li S, Jiang J, et al,. 2010b. Preventive effects of Flos Perariae (Gehua) water extract and its active ingredient puerarin in rodent alcoholism models. Chin Med 5: 36.
160. Zhao M, Du YQ, Yuan L, Wang NN,. 2010. Protective effect of puerarin on acute alcoholic liver injury. Am J Chin Med 38: 241-249.
161. Zhao Y, Zhou Y,. 2012. Puerarin improve insulin resistance of adipocyte through activating Cb1 binding protein path. Chin J Integr Med 18: 293-298.
162. Zheng P, Ji G, Ma Z, et al,. 2009. Therapeutic effect of puerarin on non-alcoholic rat fatty liver by improving leptin signal transduction through JAK2/STAT3 pathways. Am J Chin Med 37: 69-83.
163. Zheng PY, Ma ZS, Hua YQ, et al,. 2008. Effects of puerarin on expressions of leptin receptor mRNA, phosphorylated Janus kinase 2/phosphorylated signal transducers and activators of transcription 3 proteins in the liver of rats with non-alcoholic fatty liver. Zhong Xi Yi Jie He Xue Bao 6: 921-927.
164. Zhou J, Wang H, Xiong Y, et al,. 2010. Puerarin attenuates glutamate-induced neurofilament axonal transport impairment. J Ethnopharmacol 132: 150-156.
165. Zhou PQ, Shen L, Yang YP, Xie J,. 2006. Clinical observation of puerarin in treating patients with vertebral artery insufficiency due to cervical spondylosis: a report of 123 cases. Zhong Xi Yi Jie He Xue Bao 4: 80-81.
166. Zhu G, Wang X, Chen Y, et al,. 2010a. Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease. Planta Med 76: 1820-1826.
167. Zhu G, Wang X, Wu S, et al,. 2013. Neuroprotective effects of puerarin on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson's disease model in mice. Phytother Res Mar 20. doi: 10.1002/ptr.4975.
168. +-induced human neuroblastoma SH-SY5Y cell death. Neurochem Int 60: 400-408.
169. Zhu J, Wang X, Shang Y, et al,. 2008a. Puerarin reduces endothelial progenitor cells senescence through augmentation of telomerase activity. Vascul Pharmacol 49: 106-110.
170. Zhu LH, Wang L, Wang D, et al,. 2010b. Puerarin attenuates
171. Zhu QL, He AX, Han HR, et al,. 2002. The potential effect of puerarin in preventing atherosclerosis. CJIM 8: 290-294.
172. Zhu YM, Ni C, Zhu L, et al,. 2011. Effect and mechanism of puerarin on high glucose-induced hypo-responses in vascular contraction. Zhongguo Ying Yong Sheng Li Xue Za Zhi 27: 62-65.
173. Zhu Z, Xu Y, Zou H, et al,. 2008b. Effects of puerarin on pulmonary vascular remodeling and protein kinase C-alpha in chronic cigarette smoke exposure smoke-exposed rats. J Huazhong Univ Sci Technolog Med Sci 28: 27-32.
174. Zou Y, Hong B, Fan L, et al,. 2013. Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: involvement of the GSK-3β/Nrf2 signaling pathway. Free Radic Res 47: 55-63.